Filing Details

Accession Number:
0001209191-21-024224
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-01 18:12:37
Reporting Period:
2020-03-30
Accepted Time:
2021-04-01 18:12:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1807120 Design Therapeutics Inc. DSGN Pharmaceutical Preparations (2834) 823929248
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1848372 Arsani William C/o Design Therapeutics, Inc.
6005 Hidden Valley Road, Suite 110
Carlsbad CA 92011
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-30 1,217,627 $0.00 1,217,627 No 4 C Indirect By Logos Opportunities Fund II, L.P.
Common Stock Acquisiton 2021-03-30 814,874 $0.00 2,032,501 No 4 C Indirect By Logos SPV I LP
Common Stock Acquisiton 2021-03-30 700,000 $20.00 2,732,501 No 4 P Indirect By Logos Global Master Fund LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By Logos Opportunities Fund II, L.P.
No 4 C Indirect By Logos SPV I LP
No 4 P Indirect By Logos Global Master Fund LP
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Preferred Stock Disposition 2021-03-30 1,984,733 $0.00 1,217,627 $0.00
Common Stock Series B Preferred Stock Disposition 2021-03-30 1,328,245 $0.00 814,874 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect. The Preferred Stock has no expiration date.
  2. The Reporting Person is a managing member of Logos Opportunities Fund II, L.P. and Logos SPV 1 LP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  3. Logos Global Management LP ("LGM") is the investment adviser of private funds, including Logos Global Master Fund LP (the "Fund"). Logos GP LLC ("Fund GP") is the general partner of the Fund. The Reporting Person is the Manager of Fund GP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.